miR-20a regulates expression of the iron exporter ferroportin in lung cancer
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
MicroRNAs (miRNAs) are a class of small non-coding RNAs that negatively regulate gene expression by base pairing to partially complementary sites within the 3′-untranslated regions (3′UTR) of target messenger RNAs (mRNA) [ 1 ]. Binding of miRNA to its target mRNA causes translation repression [ 2 ] and/or mRNA degradation [ 3 ]. Genome-wide profiling of miRNA expression in cancer samples and their corresponding normal tissues showed a distinguished signature between tumoral and normal cells [ 4 , 5 ], which is often associated with cancer prognosis and progression [ 6 – 8 ]. In particular, a well-characterized polycistronic miRNA cluster, the miR-17-92 family, accomplishes pleiotrophic functions in cancer [ 9 , 10 ]. It is highly conserved among vertebrates [ 11 ] and has two mammalian paralogs: the miR-106a-363 and the miR-106b-25 cluster [ 12 ]. The miRNAs encoded by miR-17-92 and its two paralogs can be categorized into four “seed” families according to their seed sequences: miR-17 family (including miR-17, miR-20a, miR-20b, miR-106a, miR-106b and miR-93), miR-18 family (miR-18a and miR-18b), miR-19 family (miR-19a, miR-19b-1 and miR-19b-2), and miR-92 family (miR-92a-1, miR-92a-2, miR-25, and miR-363) [ 13 ]. Overexpression of the miR-17-92 cluster has been observed in a variety of hematological malignancies and solid tumors including B cell lymphoma, B cell chronic lymphocytic leukemia (CLL), retinoblastoma, meduloblastoma, osteosarcoma, and cancers of the colon, pancreas, breast, lung, kidney, and liver (as reviewed in [ 13 ]). The miRNA members of the miR-17-92 cluster contribute to cancer pathogenesis by directly regulating genes associated with cell growth and proliferation. The miR-17 family (miR-17 and miR-20a) triggers rapid proliferation by repressing the cell cycle inhibitors p21 (CDKN1A) and p57 (CDKN1C) [ 14 , 15 ] as well as by directly targeting the proapoptotic protein Bim (BCL211) [ 16 ] and the tumor suppressor gene phosphatase and tensin homolg (PTEN) [ 17 ]. Furthermore, they also regulate genes that mold the conditions for cellular proliferation. miR-17-92 blocks the production of transforming growth factor (TGF)-β-dependent antiangiogenic factors through suppressing the TGF-β receptor II (TGFBRII), Smad2, and Smad4 [ 18 ] whereas miR-18a and miR-19 promotes angiogenesis by directly targeting thrombospondin 1 (TSP-1) and connective tissue growth factor (CTGF), respectively [ 19 ].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 3×
“changes in FPN expression affect the labile iron pool (LIP) [31, 48, 54] and thus will influence intracellular availability of this important nutrient.”
BackgroundMicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., & Marks, D. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020363 · Cited by 3,796 · cited 1×
“target prediction algorithms: miRanda [42], Targetscan [43], PicTar [44], and RNA22 [45].”
MethodUnique microRNA molecular profiles in lung cancer diagnosis and prognosis
Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.01.025 · Cited by 3,023 · cited 1×
“Genome-wide profiling of miRNA expression in cancer samples and their corresponding normal tissues showed a distinguished signature between tumoral and normal cells [4, 5], which is often associated with cancer prognosis and progression [6–8].”
BackgroundTwo to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120 · cited 1×
“[25].”
Self-citationIron and cancer: more ore to be mined
Torti, S. V., & Torti, F. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3495 · Cited by 1,621 · cited 2×
“In addition, most cell types express low levels of FPN, including cancer cells [26].”
BackgroundMcKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
The role of iron regulatory proteins in mammalian iron homeostasis and disease
Rouault, T. A. (2006) · Nature Chemical Biology · doi:10.1038/nchembio807 · Cited by 1,055 · cited 1×
“This adds an additional level of complexity to the control of FPN expression, which was previously shown to be regulated at the transcriptional, translational, and post-translational level [27–29, 31, 32, 51].”
BackgroundMogilyansky, E., & Rigoutsos, I. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.125 · Cited by 889 · cited 5×
“and cancers of the colon, pancreas, breast, lung, kidney, and liver (as reviewed in [13]).”
BackgroundInfluential
Cited by
Ferroptosis, a new form of cell death: opportunities and challenges in cancer
Mou, Y., Wang, J., Wu, J., He, D., Zhang, C., Duan, C., & Li, B. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0720-y · Cited by 1,930
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Self-citationMechanisms controlling cellular and systemic iron homeostasis
Galy, B., Conrad, M., & Muckenthaler, M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00648-1 · Cited by 785
Self-citationHepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Nemeth, E., & Ganz, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126493 · Cited by 540
“There is evidence that microRNAs such as miR-485-3p, miR-20a and miR-20b, can posttranscriptionally downregulate ferroportin but the physiological role of this mechanism is uncertain [37,39,40].”
BackgroundChen, X., Yin, J., Qu, J., & Huang, L. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006418 · Cited by 350
Metadata
- Authors
- Babu, K. R., & Muckenthaler, M. U.
- Venue
- Journal of Molecular Medicine
- Published
- 2015-11-12
- Volume
- 94
- Issue
- 3
- Pages
- 347-359
- ISSN
- 0946-2716 (ISSN-L)
- 1432-1440
- OpenAlex
- W2147072294
- Cited by
- 101
- References
- 23
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: miR-20a regulates expression of the iron exporter ferroportin in lung cancer. https://app.cochat.ai/papers/10.1007/s00109-015-1362-3
- The paper
- Babu, K. R., & Muckenthaler, M. U. (2016). miR-20a regulates expression of the iron exporter ferroportin in lung cancer. Journal of Molecular Medicine. https://doi.org/10.1007/s00109-015-1362-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.